The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Astellas Pharma; BMSi; Eisai; Ipsen; Pfizer; Sanofi
Speakers' Bureau - AstraZeneca/MedImmune; BMSi; Ipsen; Roche
Research Funding - AstraZeneca/MedImmune; BMSi (Inst); Exelixis (Inst); Pfizer (Inst); Roche Belgium (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche
CALYPSO: A three-arm randomized phase II study of durvalumab alone or with savolitinib or tremelimumab in previously treated advanced clear cell renal cancer.
 
Thomas Powles
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson; Merck; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen
Research Funding - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Ipsen; Johnson & Johnson; Merck; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; MSD; Pfizer; Roche
 
Maria Jose Mendez-Vidal
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Roche
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Janssen-Cilag; Novartis; Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Janssen-Cilag; Pfizer; Roche
 
Alejo Rodriguez-Vida
Honoraria - Astellas Oncology; AstraZeneca Spain; Bayer; Bristol-Myers Squibb; Janssen; MSD; Pfizer; Roche
Consulting or Advisory Role - Astellas Oncology; Bayer; BMSi; Clovis Oncology; Ipsen; Janssen; MSD; Pfizer; Roche
Research Funding - MSD (Inst); Pfizer; Takeda (Inst)
Travel, Accommodations, Expenses - Astellas Oncology; Bayer; BMSi; Clovis Oncology; Ipsen; Janssen; Novartis
 
Begoña Pérez-Valderrama
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Novartis; Pierre Fabre
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag
 
Emilio Esteban
Travel, Accommodations, Expenses - Pfizer/EMD Serono
 
Fiona Thistlethwaite
Honoraria - Bayer
Consulting or Advisory Role - Bristol-Myers Squibb; Enara Bio; GlaxoSmithKline; Immatics; Ixaka; Janssen; Pfizer (Inst); T-Knife; Zelluna
Research Funding - 3-V Biosciences (Inst); Abbvie (Inst); Actuate Therapeutics (Inst); Adaptimmune (Inst); Adaptimmune (Inst); Agalimmune (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); BerGenBio (Inst); Blueprint Medicines (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Carrick Therapeutics (Inst); CytomX Therapeutics (Inst); Eisai (Inst); GenMab (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Immutep (Inst); Incyte (Inst); Janssen (Inst); kinex (Inst); Lilly (Inst); Macrogenics (Inst); MedImmune (Inst); Merck (Inst); Millenium Pharamceuticals (Inst); MSD (Inst); Novartis (Inst); Octimet (Inst); Orion (Inst); Pfizer (Inst); Redx Pharma (Inst); Roche (Inst); Roche (Inst); Sierra Oncology (Inst); Synthon (Inst); Takeda (Inst); Tarveda Therapeutics (Inst)
Travel, Accommodations, Expenses - Ixaka
Other Relationship - iMatch
 
Poulam M. Patel
Speakers' Bureau - Britol Myers Squibb (Inst)
Research Funding - Scancell (Inst)
Travel, Accommodations, Expenses - EUSA Pharma
 
Urbano Anido Herranz
Honoraria - Bayer; Bristol-Myers Squibb; Eisai Europe; Novartis; Pfizer
Consulting or Advisory Role - Ipsen; Pfizer
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - Ipsen; Novartis; Pfizer; Roche
 
Gopalakrishnan Srinivasan
No Relationships to Disclose
 
Abdel Hamid
No Relationships to Disclose
 
James Larkin
Honoraria - Agence Unik; Bristol-Myers Squibb; Cambridge Healthcare research; Eisai; Incyte; Merck Serono; Novartis; Pfizer; RCGP; Royal College of Physicians; touchEXPERTS; touchIME; VJOncology
Consulting or Advisory Role - Agence Unik; Apple Tree Partners; Aptitude Health; AstraZeneca; Bristol-Myers Squibb; Calithera Biosciences; Debiopharm Group; eCancer; Eisai; EUSA Pharma; GlaxoSmithKline; Goldman Sachs; Incyte; Insel Gruppe; iOnctura; Ipsen; Merck Serono; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Seagen; Ultimovacs
Research Funding - Achilles Therapeutics (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Covance (Inst); Immunocore (Inst); MSD (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Pierre Fabre; Roche/Genentech
 
Christy Ralph
Honoraria - Bristol-Myers Squibb; Eisai; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Eisai (Inst); Merck (Inst); Roche (Inst); Viralytics (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; GlaxoSmithKline; Ipsen; Janssen; Roche
 
Stefan N. Symeonides
Consulting or Advisory Role - Bicycle Therapeutics (Inst); Boxer Capital (Inst); Bristol-Myers Squibb (Inst); Duke Street Bio (Inst); Eisai (Inst); Ellipses Pharma (Inst); EUSA Pharma (Inst); MedAnnex (Inst); MSD (Inst); Pfizer/EMD Serono (Inst); Vaccitech (Inst)
Speakers' Bureau - Bristol-Myers Squibb (Inst); EUSA Pharma (Inst); Ipsen (Inst)
Research Funding - BiolineRx (Inst); BioNTech (Inst); Boston Pharmaceuticals (Inst); Incyte (Inst); Merck Sharp & Dohme (Inst); Nouscom (Inst); Nucana (Inst); Roche/Genentech (Inst); Sapience Therapeutics (Inst); Sierra Oncology (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - BioNTech; Bristol-Myers Squibb; Ipsen; MSD
 
Javier Puente
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen-Cilag; Merck Sharp & Dohme; Pfizer; Roche; Sanofi
Research Funding - Astellas Pharma; Pfizer; Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; MSD Oncology; Pfizer; Roche
 
Ryan Hartmaier
Employment - AstraZeneca/MedImmune
 
Aleksandra Markovets
Employment - AstraZeneca/MedImmune
 
Aaron Prendergast
No Relationships to Disclose
 
Kelly Mousa
Research Funding - AstraZeneca (Inst); Merck (Inst); Roche/Genentech (Inst)
 
Cristina Suarez
No Relationships to Disclose